Tech Company Financing Transactions

858 Therapeutics Funding Round

858 Therapeutics, based in San Diego, raised $50 million from Avidity Partners, Alexandria Venture Investments and Insight Venture Partners.

Transaction Overview

Company Name
Announced On
9/27/2024
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series B
Proceeds Purpose
The company intends to use the funds for ongoing clinical development of PARG inhibitor ETX-19477 and further advancement of its pipeline.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4757 Nexus Center Dr. 150
San Diego, CA 92121
USA
Email Address
Overview
858 Therapeutics is a biotechnology and drug discovery company developing a portfolio of small molecule drugs that act on novel therapeutic targets in oncology, including proteins that regulate RNA and the innate immune response. 858 was founded by a veteran team who together bring a track record of success in pharma and biotech drug discovery.
Profile
858 Therapeutics LinkedIn Company Profile
Social Media
858 Therapeutics Company Twitter Account
Company News
858 Therapeutics News
Facebook
858 Therapeutics on Facebook
YouTube
858 Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jeffrey Stafford
  Jeffrey Stafford LinkedIn Profile  Jeffrey Stafford Twitter Account  Jeffrey Stafford News  Jeffrey Stafford on Facebook
Chief Scientific Officer
James Veal
  James Veal LinkedIn Profile  James Veal Twitter Account  James Veal News  James Veal on Facebook
Vice President
Gretchen Bain
  Gretchen Bain LinkedIn Profile  Gretchen Bain Twitter Account  Gretchen Bain News  Gretchen Bain on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/27/2024: senvo venture capital transaction
Next: 9/27/2024: Quin AI venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document all VC transactions involving tech companies. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary